Literature DB >> 25759531

Effect of bifidobacterium on defensin-5 expression in intestinal injury of preweaning rats.

Wei Wang1, Shu-Fen Yang1, Li-Hong Ren1, Xiu-Xiu Zhang1, Shui-Lian Yu1.   

Abstract

AIM: To investigate the protective effect of bifidobacterium in endotoxin-induced intestinal injury in preweaning rats.
METHODS: Preweaning rats were randomly divided into three groups (n = 40 for each): a control group (group C), a model group (group E) and a treatment group (group T). Both groups E and T were intraperitoneally injected with lipopolysaccharide (LPS) at a dose of 5 mg/kg (5 mg/L in normal saline), and group T was intragastrically administrated with bifidobacterium suspension (2.0 × 10(9) CFU/mL, 0.5 mL each time, twice a day, until the end of the experiment) 7 d before LPS administration. Group C was intraperitoneally injected with normal saline. After intraperitoneal injection and intragastric administration, the rats were placed back to the initial cage to receive breast feeding. The rats were killed at 2, 6, 12, 24 or 72 h, respectively, after endotoxin or physiological saline injection to collect serum and ileal tissue samples. Myeloperoxidase (MPO) contents in serum and ileum were detected at different times, and expression of ileal defensin-5 mRNA was evaluated by reverse transcription-polymerase chain reaction.
RESULTS: Serum and ileal MPO contents in group E were significantly higher than those in group C (serum contents: 107.50 ± 17.70 vs 157.14 ± 24.67, P < 0.05; ileal contents: 1.03 ± 0.21 vs 1.57 ± 0.33, P < 0.05), which peaked at 12 h and 6 h, respectively. MPO contents in group T were significantly lower than those in group E (serum contents: 114.38 ± 24.56 vs 145.25 ± 23.62, P < 0.05; ileal contents: 1.25 ± 0.24 vs 1.57 ± 0.33, P < 0.05). The expression of defensin-5 mRNA in group E was significantly higher than that in group C (0.953 ± 0.238 vs 0.631 ± 0.146, P < 0.05), which peaked at 2 h, and then decreased gradually. The expression of defensin-5 mRNA in group T was significantly lower than that in group E (0.487 ± 0.149 vs 0.758 ± 0.160, P < 0.05) apparently in 24 h. The expression of defensin-5 mRNA at 2 h in group T was significantly higher than that in group C (0.824 ± 0.158 vs 0.631 ± 0.146, P < 0.05).
CONCLUSION: MPO and defensin-5 mRNA increase in preweaning rats with LPS-induced intestinal injury. Bifidobacterium protects the gut by inhibiting MPO activity, not by increasing defensin-5 secretion.

Entities:  

Keywords:  Bifidobacterium; Defensin-5; Ileum; Lipopolysaccharide; Myeloperoxidase

Mesh:

Substances:

Year:  2015        PMID: 25759531      PMCID: PMC4351213          DOI: 10.3748/wjg.v21.i9.2638

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  Reduction of E-cadherin by human defensin-5 in esophageal squamous cells.

Authors:  Yoshiki Nomura; Hiroki Tanabe; Kentaro Moriichi; Satomi Igawa; Katsuyoshi Ando; Nobuhiro Ueno; Shin Kashima; Motoya Tominaga; Takuma Goto; Yuhei Inaba; Takahiro Ito; Akemi Ishida-Yamamoto; Mikihiro Fujiya; Yutaka Kohgo
Journal:  Biochem Biophys Res Commun       Date:  2013-08-16       Impact factor: 3.575

Review 2.  [Defensins in the honeybee antinfectious protection].

Authors:  R A Il'iasov; L R Gaĭfullina; E S Saltykova; A V Poskriakov; A G Nikolenko
Journal:  Zh Evol Biokhim Fiziol       Date:  2012 Sep-Oct

3.  Intestinal alpha-defensin expression in pediatric inflammatory bowel disease.

Authors:  M Zilbauer; A Jenke; G Wenzel; D Goedde; J Postberg; A D Phillips; M Lucas; G Noble-Jamieson; F Torrente; C Salvestrini; R Heuschkel; S Wirth
Journal:  Inflamm Bowel Dis       Date:  2010-12-16       Impact factor: 5.325

4.  Anti-inflammatory properties of intestinal Bifidobacterium strains isolated from healthy infants.

Authors:  Ekaterina V Khokhlova; Vladimir V Smeianov; Boris A Efimov; Lyudmila I Kafarskaia; Svetlana I Pavlova; Andrei N Shkoporov
Journal:  Microbiol Immunol       Date:  2012-01       Impact factor: 1.955

5.  Rebamipide inhibits indomethacin-induced small intestinal injury: possible involvement of intestinal microbiota modulation by upregulation of α-defensin 5.

Authors:  Tetsuya Tanigawa; Toshio Watanabe; Koji Otani; Yuji Nadatani; Fumikazu Ohkawa; Mitsue Sogawa; Hirokazu Yamagami; Masatsugu Shiba; Kenji Watanabe; Kazunari Tominaga; Yasuhiro Fujiwara; Koji Takeuchi; Tetsuo Arakawa
Journal:  Eur J Pharmacol       Date:  2013-02-18       Impact factor: 4.432

6.  Pro-inflammatory and pro-apoptotic properties of Human Defensin 5.

Authors:  Wuyuan Lu; Erik de Leeuw
Journal:  Biochem Biophys Res Commun       Date:  2013-06-11       Impact factor: 3.575

7.  Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.

Authors:  Aiping Wang; Fang Chen; Yingjie Wang; Mingqiang Shen; Yang Xu; Jian Hu; Song Wang; Fang Geng; Cheng Wang; Xinze Ran; Yongping Su; Tianmin Cheng; Junping Wang
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

8.  Stimulation of the follicular bulge LGR5+ and LGR6+ stem cells with the gut-derived human alpha defensin 5 results in decreased bacterial presence, enhanced wound healing, and hair growth from tissues devoid of adnexal structures.

Authors:  Denver Lough; Hui Dai; Mei Yang; Joel Reichensperger; Lisa Cox; Carrie Harrison; Michael W Neumeister
Journal:  Plast Reconstr Surg       Date:  2013-11       Impact factor: 4.730

Review 9.  Defensins in innate immunity.

Authors:  Le Zhao; Wuyuan Lu
Journal:  Curr Opin Hematol       Date:  2014-01       Impact factor: 3.284

Review 10.  Antiviral mechanisms of human defensins.

Authors:  Sarah S Wilson; Mayim E Wiens; Jason G Smith
Journal:  J Mol Biol       Date:  2013-10-02       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.